ライフサイエンスコーパス: complete adjuvant

1 odel of adjuvant-induced arthritis (Freund's complete adjuvant).

2 methylated bovine serum albumin and Freund's complete adjuvant.

3 e by immunization with collagen and Freund's complete adjuvant.

4 AA was induced in Lewis rats using Freund's complete adjuvant.

5 unization with type II collagen and Freund's complete adjuvant.

6 ollowing subcutaneous injections of Freund's complete adjuvant, a basal presence of ir-dynorphin A(1-

7 ansplantation and immunization with Freund's complete adjuvant along with multiple injections of allo

8 e immunized with HEL (25 microg) in Freund's complete adjuvant and 14 days later were tested for immu

9 constriction injury), inflammatory (Freund's complete adjuvant and carrageenan, plantar incision) and

10 ated bovine serum albumin (mBSA) in Freund's complete adjuvant and then challenged on day 21 by intra

11 age using type II chicken collagen, Freund's complete adjuvant, and, on occasion, a lipopolysaccharid

12 nt, mice were immunized with CII in Freund's complete adjuvant (CFA) and treated with a single dose o

13 ssion in mice receiving formalin or Freund's complete adjuvant (CFA) as an inflammatory stimulus.

14 joint was produced by injection of Freund's complete adjuvant (CFA) into the knee joint of young adu

15 e were immunized with bovine CII in Freund's complete adjuvant (CFA) or in CFA alone.

16 K) fusion protein along with either Freund's complete adjuvant (CFA) or U1 RNA.

17 e II collagen (CII) emulsified with Freund's complete adjuvant (CFA), and compared with PGIA and CIA

18 ized with type II collagen (CII) in Freund's complete adjuvant (CFA).

19 ia intraarticular (IA) injection of Freund's complete adjuvant (CFA).

20 immunized with rCIX emulsified with Freund's complete adjuvant (CFA).

21 lpha or intraarticular injection of Freund's complete adjuvant (CFA).

22 7; 95% CI 1.16-2.68; P=0.008) and failure to complete adjuvant chemotherapy (OR 1.47; 95% CI 1.20-1.8

23 s and correlates of fatigue in women who had completed adjuvant chemotherapy for breast cancer and in

24 patients with resected colon cancer who had completed adjuvant chemotherapy to participate in a stru

25 ease recurrence during or within 6 months of completing adjuvant chemotherapy.

26 quid CDx assay, after recurrence on or after completing adjuvant endocrine therapy.

27 e heat hypersensitivity produced by Freund's Complete Adjuvant (FCA).

28 ed in alum but not when injected in Freund's complete adjuvant (FCA).

29 ent, Lewis rats were immunized with Freund's complete adjuvant followed by administration of IL-21R.F

30 mice with type II collagen (CII) in Freund's complete adjuvant, followed 3 weeks later by CII in Freu

31 en in four typical adjuvants: alum, Freund's complete adjuvant, Freund's incomplete adjuvant, and mon

32 nd MRL/MpJ mice were immunized with Freund's complete adjuvant in the presence or absence of human pl

33 For experimental verification FCA (Freund's complete adjuvant)-induced chronic arthritis model emplo

34 was induced in rats by injection of Freund's complete adjuvant into the hind footpad.

35 her before immunization with CII in Freund's complete adjuvant or after initiation of arthritis.

36 ry agent (carrageenan; CARR or FCA; Freund's complete adjuvant) or nerve injury (axotomy; AXO, partia

37 l administration of thioglycollate, Freund's complete adjuvant, or heat-killed C. albicans followed b

38 zed with murine type II collagen in Freund's complete adjuvant, resulting in a chronic relapsing poly

39 Intervention with Freund's complete adjuvant, semi-allogeneic splenocytes, and temp

40 Sixteen patients (30%) failed to complete adjuvant therapy, due to disease progression (7

41 nalysis; however, only 12.5% of patients had completed adjuvant therapy, and the HR for overall survi

42 he first OS IA, the majority of patients had completed adjuvant therapy, IDFS remained consistent, an

43 nt was injected with saline or with Freund's complete adjuvant to induce arthritis.

44 The median cost of a complete adjuvant treatment was $158 000 per patient.

45 , neoadjuvant therapy, and surgery have been completed; adjuvant treatment and follow-up are ongoing.

46 One month after completing adjuvant treatment, six patients still in rem

47 to wear postoperatively until 3 months after completing adjuvant treatments.

48 T-B dipeptide emulsified in Freund's complete adjuvant was able to induce strong antiviral an

49 nitrophenyl-bovine serum albumin in Freund's complete adjuvant were significantly inhibited by oral a

50 Freund's complete adjuvant were used to induce joint inflammation

51 ouse model by coupling injection of Freund's complete adjuvant with infusion of allogeneic spleen cel